BCL2 and osteosarcoma: On the other hand, Jiang et al. used a Dox-inducible system to express B cell lymphoma-2 (Bcl-2) interacting mediator of cell death (Bim) and truncated BH3 interacting death domain agonist (tBid) in human osteosarcoma U2OS cells [8].